United Therapeutics
UTHR
#996
Rank
NZ$39.87 B
Marketcap
NZ$909.72
Share price
-1.82%
Change (1 day)
69.42%
Change (1 year)

Market capitalization of United Therapeutics (UTHR)

Market cap: NZ$39.87 Billion

As of March 2026 United Therapeutics has a market cap of NZ$39.87 Billion. This makes United Therapeutics the world's 996th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of United Therapeutics from 1999 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$39.87 B0.67%
2025NZ$39.60 B38.99%
2024NZ$28.49 B74.39%
2023NZ$16.34 B-18.15%
2022NZ$19.96 B40.12%
2021NZ$14.24 B52.39%
2020NZ$9.34 B62.89%
2019NZ$5.73 B-18.9%
2018NZ$7.07 B-21.39%
2017NZ$9.00 B2.49%
2016NZ$8.78 B-16.12%
2015NZ$10.47 B34.5%
2014NZ$7.78 B12.28%
2013NZ$6.93 B112.85%
2012NZ$3.25 B-7.76%
2011NZ$3.53 B-25.12%
2010NZ$4.71 B20%
2009NZ$3.93 B56.98%
2008NZ$2.50 B-11.72%
2007NZ$2.83 B71.13%
2006NZ$1.65 B-29.72%
2005NZ$2.35 B66.16%
2004NZ$1.41 B88.63%
2003NZ$0.75 B12.69%
2002NZ$0.66 B31.68%
2001NZ$0.50 B-25.45%
2000NZ$0.68 B-51.72%
1999NZ$1.40 B

End of Day market cap according to different sources

On Mar 27th, 2026 the market cap of United Therapeutics was reported to be:

NZ$39.87 Billion
by Nasdaq info icon info icon
NZ$39.87 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
NZ$267.63 B 571.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$1.367 T 3,330.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
NZ$14.34 B-64.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$289.93 B 627.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Cardinal Health
CAH
NZ$84.58 B 112.14%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$188.69 B 373.27%๐Ÿ‡ฌ๐Ÿ‡ง UK
Cytokinetics
CYTK
NZ$13.39 B-66.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$58.24 B 46.07%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel